TOKYO (AFP): Japanese pharmaceutical company Takeda said the European Union had given the green light to its dengue fever vaccine, making it the second jab preventing the disease to be approved by the bloc.
Mosquito-borne dengue can cause hemorrhagic fever and infects an estimated 100 to 400 million people yearly, although over 80 per cent of cases are mild or asymptomatic, the WHO says.
Already a subscriber? Log in.
Save 30% and win Bosch appliances! More Info
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
